Board Member and Chair of Compensation Committee, SaNOtize Research and Development Corp.; Board Member & Chair of Nominating and Governance Committee & Audit Committee Member, VistaGen Therapeutics, Inc.; Board Chair, Momentum for Health

Mary Rotunno is a mission-driven health-care C-suite executive and public corporate board director with the strategic vision to critically think through complex challenges, see around corners, and mitigate risk. As a clinician and leader, she brings insight, gained through empathy and listening, and industry expertise from patient and health-system perspectives to public/private company boards in pharmaceuticals, health information technology, biotechnology, population health management, value-based care, and fitness and wellness models and products. Rotunno currently serves on the audit committee and chairs the nominating and governance committee at Vistagen Therapeutics (Nasdaq: VTGN), a biopharmaceutical company developing new-generation treatment for anxiety and depression, and serves on the board of the private company SaNOtize, chairing the compensation committee.